Embargo Policy
All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.
The most noteworthy abstracts in the areas of hepatitis C, inflammatory bowel disease, fecal microbiota transplantation for Clostridium difficile, drug-induced liver injury, nonalcoholic fatty liver disease, as well as several case reports warning about the dangers of nutritional supplements are discussed in these virtual press briefings, which are available for instant access here on the new ACG Blog.
Additional ACG 2014 abstract highlights with author insights are also available on the ACG Blog, such as increased incidence of young onset colorectal cancer, new data regarding Lynch syndrome and importance of screening, breath detection of potential biomarkers for IBS,risk of eosinophilic esophagitis in patients with celiac disease, and findings from a two-year safety study of patients on linaclotide.
All featured ACG 2014 abstracts, author insights and contact information are easily accessible by abstract category here on the ACG Blog:
Inflammatory Bowel Disease (IBD)
Media Interview Requests:
Press room and video recording facilities will be available onsite. To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000. From Sunday, October 19 – Wednesday, October 22, in ACG Press Room (Room 119A; Phone 215- 418-2358) at the Pennsylvania Convention Center in Philadelphia.